European Medicines Agency - Regulatory - Regulation of medicines

5 -Training and educational capacity to build competencies



    Description

Name

 

EBMT PDWP - European Society for Blood and Marrow Transplantation, Paediatric Diseases Working Party

Evidence of collaboration with regulatory authorities Yes
Capacity to provide competent consultation to regulatory authorities Yes
Formal meetings for clinical trials Yes at least 2 per year for the FORUM study, 2 PDWP board meetings to discuss the progress on the ongoing studies and the approval of new ones
Training courses given over the last 2 years Yes Two training courses: 2023: Midterm Meeting on New indications in Immune Dysregulatory, Autoinflammatory and Autoimmune Diseases 2024: Educational meeting on Complications post CAR-T Cell Therapy in Paediatric and Adult Patients (postponed to 01/2025 due to wheather alert)
Training courses received over the last 2 years Yes
Promotion of participation in clinical trials in countries with limited resources Yes
List of Countries